Archimedes Vascular is a medical company that treats patients with hypertension, and provides a delivery catheter system with barostats.
Archimedes Vascular has raised $2.2M in total funding. The most recent round was Series A. The last funding was announced in June 2025.
Archimedes Vascular's investors include Sherpa Healthcare Partners.
Archimedes Vascular is headquartered in Birmingham, United States.
Archimedes Vascular is a medical company that treats patients with hypertension, and provides a delivery catheter system with barostats.
Archimedes Vascular is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Archimedes Vascular — Funding & Investors." VCBacked, June 23, 2025, https://www.vcbacked.co/company/archimedes-vascular. Accessed August 15, 2026.
VCBacked. (2025). Archimedes Vascular — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/archimedes-vascular
{{cite web |title=Archimedes Vascular — Funding & Investors |url=https://www.vcbacked.co/company/archimedes-vascular |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated